Beta-Hydroxybutyrate Augments Oxaliplatin-Induced Cytotoxicity by Altering Energy Metabolism in Colorectal Cancer Organoids

Beta-Hydroxybutyrate Augments Oxaliplatin-Induced Cytotoxicity by Altering Energy Metabolism in Colorectal Cancer Organoids

Deregulation of cellular metabolism has recently emerged as a notable cancer characteristic. This reprogramming of key metabolic pathways supports tumor growth. Targeting cancer metabolism demonstrates the potential for managing colorectal cancer. Beta-hydroxybutyrate (BOHB) acts as an acetyl-CoA so...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Sever, Tolga, Ellidokuz, Ender Berat, Basbinar, Yasemin, Ellidokuz, Hulya, Yilmaz, Ömer H., Calibasi-Kocal, Gizem
Andere auteurs:	Massachusetts Institute of Technology. Department of Biology
Formaat:	Artikel
Gepubliceerd in:	Multidisciplinary Digital Publishing Institute 2023
Online toegang:	https://hdl.handle.net/1721.1/153248

Gelijkaardige items

Stratifiers for oxaliplatin outcome in colorectal cancer
door: Hassanieh, S
Gepubliceerd in: (2021)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.
door: Madi, A, et al.
Gepubliceerd in: (2012)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: The MRC COIN trial
door: Madi, A, et al.
Gepubliceerd in: (2012)

Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer
door: Urbanska, Aleksandra M., et al.
Gepubliceerd in: (2015)

In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis
door: Taylor, Martin S., et al.
Gepubliceerd in: (2018)

Pattern recognition receptor polymorphisms as predictors of oxaliplatin benefit in colorectal cancer
door: Gray, V, et al.
Gepubliceerd in: (2019)

A pilot study of the use of Oxaliplatin in metastatic colorectal cancer at Velindre
door: Mitra, S, et al.
Gepubliceerd in: (2001)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
door: Graf, Nora, et al.
Gepubliceerd in: (2012)

An oxaliplatin(IV) prodrug-based supramolecular self-delivery nanocarrier for targeted colorectal cancer treatment
door: Lim, Wei Qi, et al.
Gepubliceerd in: (2020)

In-depth clinical and biological exploration of DNA damage immune response as a biomarker for oxaliplatin use in colorectal cancer
door: Malla, SB, et al.
Gepubliceerd in: (2020)

Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance
door: Buzzelli, J, et al.
Gepubliceerd in: (2018)

Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature
door: Zhang, Shun, et al.
Gepubliceerd in: (2021)

Production And Characterization Of Poly(3-Hydroxybutyrate-Co-4-Hydroxybutyrate) Copolymer
door: Ahmad, Rahayu
Gepubliceerd in: (2011)

The Organoid Cell Atlas
door: Bock, Christoph, et al.
Gepubliceerd in: (2021)

Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
door: Sharma, R, et al.
Gepubliceerd in: (2007)

Hippuric acid nanocomposite enhances doxorubicin and oxaliplatin-induced cytotoxicity in MDA-MB231, MCF-7 and Caco2 cell lines.
door: Hussein Al Ali, Samer Hassan, et al.
Gepubliceerd in: (2013)

Oxaliplatin and [Pt(R,R-DACH)(panobinostat-2H)] show nanomolar cytotoxicity towards diffuse intrinsic pontine glioma (DIPG)
door: Boulet, MHC, et al.
Gepubliceerd in: (2020)

Production And Characterization Of Pol Y(3-Hydroxybutyrate Te-Co-4-Hydroxybutyrate) Copolymer
door: Ahmad, Rahayu
Gepubliceerd in: (2011)

Fabrication And Characterization Of Poly(3-Hydroxybutyrate-Co-4- Hydroxybutyrate)/Gelatin Blend Scaffolds
door: Mat Junoh, Azuraini
Gepubliceerd in: (2019)

The mechanics of human brain organoids
door: Balbi, V, et al.
Gepubliceerd in: (2020)

Engineering Stem Cell Organoids
door: Safaee, Helia, et al.
Gepubliceerd in: (2017)

Topological data analysis of organoids
door: Marsh, LM
Gepubliceerd in: (2023)

Colorectal cancer models for novel drug discovery
door: Golovko, Daniel, et al.
Gepubliceerd in: (2016)

CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA
door: Taieb, J, et al.
Gepubliceerd in: (2012)

Designing of Collagen Based Poly(3-hydroxybutyrate-co-4-hydroxybutyrate) Scaffolds for Tissue Engineering
door: S., Vigneswari, et al.
Gepubliceerd in: (2015)

Optimized Production Of Poly(3-Hydroxybutyrate) And Poly(3-Hydroxybutyrate-Co-4-Hydroxybutyrate) By Cupriavidus Sp. Usmaa2-4 In A One-Stage Fermentation
door: Md Iqbal, Nurhezreen
Gepubliceerd in: (2013)

THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS
door: Maughan, T, et al.
Gepubliceerd in: (2010)

Intermittent versus continuous oxaliplatin-based combination chemotherapy in patients with advanced colorectal cancer: a randomised non-inferiority trial (MRC COIN)
door: Adams, R, et al.
Gepubliceerd in: (2009)

Conventional cytotoxic and novel therapeutic concepts in colorectal cancer.
door: Midgley, R, et al.
Gepubliceerd in: (2001)

Enhanced production of poly (3-hydroxybutyrate-co-4-hydroxybutyrate) copolymer with manipulated variables and its properties
door: S. Vigneswari, et al.
Gepubliceerd in: (2009)

Cerebral Organoid Models for Neurotropic Viruses
door: Antonucci, Jenna, et al.
Gepubliceerd in: (2021)

Moral limits of brain organoid research
door: Koplin, JJ, et al.
Gepubliceerd in: (2020)

Cerebral Organoid Models for Neurotropic Viruses
door: Antonucci, Jenna M, et al.
Gepubliceerd in: (2021)

Advances in spheroids and organoids on a chip
door: Fang, Guocheng, et al.
Gepubliceerd in: (2023)

Three-dimensional biological cultures and organoids
door: Byrne, H, et al.
Gepubliceerd in: (2020)

Modelling medulloblastoma using cerebellar organoids
door: van Essen, MJ
Gepubliceerd in: (2022)

Transcriptome-wide in vitro effects of aspirin on patient-derived normal colon organoids
door: Devall, Matthew AM, et al.
Gepubliceerd in: (2023)

Personalized proteome profiles of healthy and tumor human colon organoids reveal both individual diversity and generic features of colorectal cancer
door: Mohammed, S, et al.
Gepubliceerd in: (2017)

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
door: Iveson, T, et al.
Gepubliceerd in: (2018)

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
door: Maughan, T, et al.
Gepubliceerd in: (2011)